Stay updated with breaking news from Medication Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kristen Peterson, PharmD, BCOP, reviews how pharmacists navigate multiple myeloma treatment, from initial diagnosis to managing adverse effects, supporting patients, ensuring medication access, and evolving roles in prolonged patient care.
Currently, only an estimated one in three patients with opioid use disorder receive any treatment for their condition due to varying health care access issues. Considering this significant gap, we invite you to register for an APhA Pulse on Practice & Policy Open Forum in collaboration with the National Association of Boards of Pharmacy, the National Alliance of State Pharmacy Associations, and NCPA. It all happens tomorrow, so don’t delay in registering.
Medical experts weigh in on the strength of collaborative care and shared decision-making in the management of metastatic breast cancer (mBC).
Social determinants of health create a myriad of obstacles to optimal care for patients receiving treatment for metastatic breast cancer.
Watch your mailboxes — the November issue of America’s Pharmacist® offers a snapshot of the opioid crisis you won’t want to miss. Right now, only an estimated 36 percent of patients with opioid use disorder receive any treatment for their condition due to varying health care access issues.